NeuroSense Therapeutics to Attend 5th Annual ROTH Healthcare Conference
NeuroSense Therapeutics management prepares for investor engagement at the 5th Annual ROTH Healthcare Opportunities Conference scheduled for September 29, 2026.
NeuroSense Therapeutics management prepares for investor engagement at the 5th Annual ROTH Healthcare Opportunities Conference scheduled for September 29, 2026.
IonQ's upcoming investor day centers on the integration of SkyWater Technology and potential technical milestones, as the market looks for a catalyst…
Trans-Oil bond prices fell sharply following a Ukraine-linked report that raised fears over the company's operational risks; the company moved quickly to…
Nvidia CEO Jensen Huang urged investors to focus on AI's long-term transformative potential, dismissing near-term spending concerns and emphasizing the company's leadership…